Cicatrix Labs Announces Launch of Assuage Brand Suppositories to the Canadian Market

February 14, 2022 9:00 AM EST | Source: Cicatrix Labs Ltd.

Kelowna, British Columbia--(Newsfile Corp. - February 14, 2022) - Cicatrix Labs Ltd, a holder of a cannabis processing license under the Cannabis Act, announces the launch of a line of cannabis suppositories through a partnership with VIVO Cannabis Inc (TSX: VIVO) (OTCQX: VVCIF) and its wholly-owned subsidiaries Canna Farms Limited and ABcann Medicinals Inc. These vaginal and rectal suppositories will be available on VIVO's Canna Farms e-commerce marketplace.

"This product launch is the first step in our mission of bringing uniquely effective cannabis products to the Canadian market. We have invested heavily in product safety and, unlike current illegal cannabis suppository sources, our suppositories are tested for pesticides, heavy metals and bacterial and fungal contamination," said Sarah Roberts, a pharmacist and Founder and President of Cicatrix Labs. "Choice is important to our customers and physicians. Not everyone is well served by the products currently available and suppositories offer an important alternative for women's health and gastrointestinal conditions. With their strong history of patient care, Canna Farms was the logical partner."

Assuage™ suppositories for vaginal or rectal use are available in two strengths: 50mg cannabidiol (CBD) and a 1:3 formulation with 10mg tetrahydrocannabinol (THC) plus 30mg CBD.

"VIVO continues to advance our focused medical strategy and to ensure that our patients have access to the best cannabis products available, including novel cannabinoid-based formulations," commented Ray Laflamme, Canna Farms' Co-Founder and VIVO's Chief Executive Officer. "We are extremely proud to be the first medical marketplace in Canada to launch the broadest range of suppositories available to all Canadian patients."

These newly launched Assuage™ vaginal and rectal suppositories are available through the Canna Farms e-commerce medical marketplace for Canadian medical clients. Patients requiring support with registration or order placement can contact VIVO's Customer Care Team at 1 (855) 882-0988 or

Cannot view this image? Visit:

Assuage Brand Cannabis Suppositories Launch to Canadian Market

To view an enhanced version of this graphic, please visit:

About Cicatrix Labs

Cicatrix Labs is a pharmacist-founded manufacturer of unique cannabinoid-infused products including topicals and suppositories. Cicatrix Labs offers an in-house line of personal care products to Licensed Producers and Medical License holders as well as custom white labeled products. For more information visit:

About VIVO Cannabis™

VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class cultivation facilities. For more information visit:

To view the source version of this press release, please visit